ArticleOncotarget2018

Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.

Caroline Roelants et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.